Trial Search Results

Correlation of Continuous Glucose Monitoring and Glucose Tolerance Testing With Pregnancy Outcomes

Diabetic pregnant patients are at risk for adverse pregnancy outcomes, including larger than expected fetuses and unplanned operative deliveries, due to elevated blood glucose levels. the one-hour glucola test is currently used to screen pregnant patients for gestational diabetes. This involves ingesting a 50-gram glucose load, followed by a blood test one hour later. We wish to compare 7-day continuous glucose monitoring to the one-hour glucola test, and determine which one correlates better with adverse pregnancy outcomes as well as which one more accurately identifies patients at risk for adverse pregnancy outcomes.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: DexCom, Inc.

Stanford Investigator(s):


  • Device: The Seven Continuous Glucose Monitoring System


Phase 1/Phase 2


Inclusion Criteria:

   - Pregnant patients

   - Age 18-50

   - Gestational age less than 28 weeks

Exclusion Criteria:

   - Minors less than 18 years of age

   - Multiple gestation

   - Known fetal anomalies

Ages Eligible for Study

18 Years - 50 Years

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Sung Joyce